Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells

Acute myeloid leukemia: 2014 Update on risk-stratification and management

(2015) Elihu H. Estey   AMERICAN JOURNAL OF HEMATOLOGY

Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials

(2014) D. A. Pollyea et al.   HAEMATOLOGICA

Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia

(2014) M. L. Guzman et al.   MOLECULAR CANCER THERAPEUTICS

ABCB5 is a limbal stem cell gene required for corneal development and repair

(2014) Bruce R. Ksander et al.   NATURE

Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion

(2013) Wei Wei et al.   APOPTOSIS

Alantolactone inhibits growth of K562/adriamycin cells by downregulating Bcr/Abl and P-glycoprotein expression

(2013) Chunhui Yang et al.   IUBMB LIFE

Acute myeloid leukemia in the elderly: do we know who should be treated and how?

(2013) Aziz Nazha et al.   LEUKEMIA & LYMPHOMA

Proteomic Profiling Identifies Distinct Protein Patterns in Acute Myelogenous Leukemia CD34+CD38- Stem-Like Cells

(2013) Steven M. Kornblau et al.   PLoS One

Preferential eradication of acute myelogenous leukemia stem cells by fenretinide

(2013) H. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Alantolactone induces cell apoptosis partially through down-regulation of testes-specific protease 50 expression

(2013) Xu-Guang Mi et al.   TOXICOLOGY LETTERS

Low-dose triptolide in combination with idarubicin induces apoptosis in AML leukemic stem-like KG1a cell line by modulation of the intrinsic and extrinsic factors

(2013) Y Liu et al.   Cell Death & Disease

Divergent effects of supraphysiologic Notch signals on leukemia stem cells and hematopoietic stem cells

(2012) M. Y. Chiang et al.   BLOOD

Current treatment of acute myeloid leukemia

(2012) Gail J. Roboz   CURRENT OPINION IN ONCOLOGY

Alantolactone induces activation of apoptosis in human hepatoma cells

(2012) Jia-Chuan Lei et al.   FOOD AND CHEMICAL TOXICOLOGY

Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells

(2012) Jaemoo Chun et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Guaianolide Sesquiterpene Lactones, a Source To Discover Agents That Selectively Inhibit Acute Myelogenous Leukemia Stem and Progenitor Cells

(2012) Quan Zhang et al.   JOURNAL OF MEDICINAL CHEMISTRY

The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML

(2011) J. Zhou et al.   BLOOD

Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells

(2010) Dominik Fuchs et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

β-Catenin Mediates the Establishment and Drug Resistance of MLL Leukemic Stem Cells

(2010) Jenny Yeung et al.   CANCER CELL

Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF- B Pathway and Generation of Reactive Oxygen Species

(2010) Y. Jin et al.   CANCER RESEARCH

The p53 tumor suppressor protein regulates hematopoietic stem cell fate

(2010) Takashi Asai et al.   JOURNAL OF CELLULAR PHYSIOLOGY

High frequency of immature cells at diagnosis predicts high minimal residual disease level in childhood acute lymphoblastic leukemia

(2010) Martin Ebinger et al.   LEUKEMIA RESEARCH

Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data

(2008) D. C. Hassane et al.   BLOOD